StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Performance
NASDAQ:CPIX opened at $1.21 on Friday. The company’s 50-day moving average is $1.29 and its two-hundred day moving average is $1.44. Cumberland Pharmaceuticals has a 1-year low of $1.19 and a 1-year high of $2.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.44 and a quick ratio of 1.26. The firm has a market capitalization of $17.17 million, a price-to-earnings ratio of -2.05 and a beta of 0.20.
About Cumberland Pharmaceuticals
Recommended Stories
- Five stocks we like better than Cumberland Pharmaceuticals
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.